Issue 5/2021
Content (12 Articles)
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
- Open Access
- Respiratory Syncytial Virus Infection
- Current Opinion
Christine Hum, Julia Loiselle, Nadine Ahmed, Tyler A. Shaw, Caroline Toudic, John Paul Pezacki
Pain Management in Chronic Pancreatitis: Summary of Clinical Practice, Current Challenges and Potential Contribution of the M-ANNHEIM Classification
- Pancreatic Surgery
- Leading Article
Alexander Schneider, Michael Hirth
Targeted Therapy Approaches for MET Abnormalities in Non-Small Cell Lung Cancer
- NSCLC
- Leading Article
Edward B. Garon, Paige Brodrick
Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Hemodialysis
- Aminoglycoside
- Review Article
Christo Cimino, Yvonne Burnett, Nikunj Vyas, Anne H. Norris
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
- Open Access
- Idiopathic Pulmonary Fibrosis
- Adis Drug Evaluation
Yvette N. Lamb
Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
- Open Access
- Thrombotic Microangiopathy
- Adis Drug Evaluation
Yahiya Y. Syed
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
- Open Access
- Addiction
- Letter to the Editor
Udo Bonnet, Heath McAnally, Norbert Scherbaum
Authors’ Reply to Bonnet et al. “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
- Addiction
- Letter to the Editor
Kirk E. Evoy, Sarvnaz Sadrameli, Jillian Contreras, Jordan R. Covvey, Alyssa M. Peckham